SCHEMBL5203660

SCHEMBL5203660

CS(=O)(=O)Nc1cccc(OC(c2c[nH]cn2)C(c2ccccc2)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
NPC1 O15118 1/20 0.36
JAK2 O60674 1/20 0.36
RAB9A P51151 1/20 0.36
PGR P06401 1/20 0.36
CYP1A2 P05177 4/20 0.36
CYP3A4 P08684 4/20 0.36
CYP2D6 P10635 4/20 0.36
TSHR P16473 4/20 0.36
CYP2C19 P33261 4/20 0.36
USP2 O75604 3/20 0.36
LMNA P02545 3/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5203302 0.78 MAOB (0.38) CYP3A4TSHRALDH1A1TP53MAPT
SCHEMBL7099092 0.72 MAPKAPK2 (0.42) NPC1JAK2RAB9ACYP1A2CYP3A4
SCHEMBL2261743 0.71 MEN1 (0.49) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL7098182 0.71 MAPKAPK2 (0.41) NPC1JAK2RAB9ACYP1A2CYP3A4
SCHEMBL7260793 0.70 KCNH2 (0.34) CYP3A4ALDH1A1KDM4EMAPTHSD17B10
Oxalic Acid SCHEMBL5201396 0.70 DRD2 (0.47) DRD2DRD4DRD3NPC1JAK2
SCHEMBL5206663 0.70 DRD2 (0.48) DRD2DRD4DRD3NPC1JAK2
SCHEMBL28104746 0.68
SCHEMBL729746 0.67 MEN1 (0.37) CYP2C19ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL28178583 0.66 PGR (0.72) DRD2DRD4DRD3PGRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed